Target intelligence / Profile preview

PPARG activating RBM14 associated long non-coding RNA 1 (PARAL1)

Target
PARAL1
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Noncoding RNA
01

Overview

PPARG activating RBM14 associated long non-coding RNA 1 (PARAL1) is a long intergenic non-coding RNA that acts as a regulator of adipocyte differentiation and immune cell function. It is specifically enriched in adipocytes and modulates the transcriptional activity of the peroxisome proliferator-activated receptor gamma (PPARγ) through physical association with the paraspeckle-associated RNA-binding protein RBM14. PARAL1 potentiates RBM14 coactivation of PPARγ, enhancing adipogenic processes; its expression is downregulated in obesity. Recent studies show that PARAL1 also regulates myeloid dendritic cell differentiation, modulates TLR-dependent innate immune signaling, and influences adaptive immunity by affecting antigen presentation. PARAL1 is not a therapeutic target in the traditional sense (i.e., not a receptor, enzyme, transporter, or transcription factor), but rather is a regulatory noncoding RNA with emerging relevance in metabolic and immunological contexts.

Other names
NR_109PPARgamma-activator RBM14-associated lncRNAParal1
02

Biological functions

Regulation of adipocyte differentiationCoactivation of PPARG-mediated transcriptionRegulation of dendritic cell differentiationRegulation of Toll-like receptor (TLR)-dependent innate immunityRegulation of adaptive immune response
03

Disease associations

Obesity (expression is decreased in obesity)Inflammation (via TLR and immune regulation)
04

Biomarkers

Expression level of PARAL1 for adipocyte differentiation stateExpression as potentially indicative of immune activation status (especially in dendritic cells)

Beyond the preview

Go deeper on PPARG activating RBM14 associated long non-coding RNA 1 (PARAL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PPARG activating RBM14 associated long non-coding RNA 1 (PARAL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call